Prognosis
The mortality rate for patients with neurofibromatosis is elevated with:
- malignant peripheral nerve sheath tumours (MPNST) (1,2)
- MPNST is the term now used to refer to malignant schwannomas, neurogenic sarcomas, malignant neurilemomas, neurofibrosarcomas and spindle cell sarcomas
- approximately 50% of MPNSTs are associated with NF-1 and are often due to malignant transformation of neurofibromas
- NF1 patients show an 8–13% lifetime risk of developing MPNSTs (1)
- MPNSTs in NF1 usually arise within a preexisting plexiform neurofibroma (PNF)
- MPNSTs in NF-1 have a male predilection and occur approximately a decade earlier than in the general population.
- central nervous system tumours
Fertility may be reduced, especially in males.
Up to 75% of affected individuals may have no complications.
Reference:
- Frahm S et al. Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients. Neurobiol of Dis 2004;16 (1): Pages 85-91.
- Hillier JC, Moskovic E. The soft-tissue manifestations of neurofibromatosis type 1.Clin Radiol 2005; 60 (9): 960-967
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page